So Hyun Lee, MS

CONTACT

Kyungim Kim, Ph.D.

CONTACT

Lead Sponsor

Korea University Guro Hospital

Collaborators

Age

19 - 79 years

Sex

ALL

Healthy Volunteers

No

•Outpatients at the Department of Anesthesiology and Pain Medicine or the Department of Physical Medicine \& Rehabilitation of the study site who received a prescription for opioid analgesics (oral, transdermal, sublingual, or buccal formulations containing oxycodone, fentanyl, tapentadol, hydrocodone, or morphine) due to chronic non-cancer pain during the study evaluation period (from IRB approval date to September 30, 2025)
•Adults aged ≥19 years and \<80 years
•Patients who voluntarily signed a written informed consent form after receiving a full explanation of the study and understanding its purpose

•Patients with active cancer
•Patients diagnosed with sickle cell disease
•Patients diagnosed with a life-limiting illness eligible for hospice or palliative care as defined in Article 2 of the 'ACT ON HOSPICE AND PALLIATIVE CARE AND DECISIONS ON LIFE-SUSTAINING TREATMENT FOR PATIENTS AT THE END OF LIFE'
•Pregnant patients
•Patients who were prescribed opioid analgesics within the past month for postoperative pain management
•Patients who were prescribed opioid analgesics within the past month for newly developed pain
•Patients with communication difficulties
•Patients who were prescribed buprenorphine for the treatment of opioid use disorder
•Patients who are deemed inappropriate for study participation at the discretion of the investigator